Get the Stockscreener App
271.00
3.29%
-9.22
After Hours:
272.00
1.00
+0.37%
Overview
News
Price History
Option Chain
Financials
Why HUM Down?
Discussions
Forecast
Dividend History
Humana Inc stock is traded at $271.00, with a volume of 1.67M.
It is down -3.29% in the last 24 hours and down -1.97% over the past month.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
See More
Previous Close:
$280.22
Open:
$280.24
24h Volume:
1.67M
Relative Volume:
0.87
Market Cap:
$32.59B
Revenue:
$123.11B
Net Income/Loss:
$1.58B
P/E Ratio:
20.80
EPS:
13.0294
Net Cash Flow:
$2.44B
1W Performance:
-8.20%
1M Performance:
-1.97%
6M Performance:
-8.15%
1Y Performance:
+5.01%
1-Day Range:
$270.35
$281.00
1-Week Range:
$270.35
$302.79
52-Week Range:
$206.87
$315.35
Humana Inc Stock (HUM) Company Profile
Name
Humana Inc
Sector
Industry
Phone
(502) 580-1000
Address
500 W MAIN ST, LOUISVILLE, KY
Compare HUM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
271.00 | 33.70B | 123.11B | 1.58B | 2.44B | 13.03 |
|
UNH
Unitedhealth Group Inc
|
358.66 | 321.06B | 422.82B | 22.09B | 25.27B | 23.09 |
|
CVS
Cvs Health Corp
|
78.44 | 98.80B | 386.46B | 4.49B | 4.78B | 3.5841 |
|
ELV
Elevance Health Inc
|
351.42 | 79.54B | 189.25B | 5.35B | 5.34B | 23.49 |
|
CI
Cigna Group
|
295.41 | 80.27B | 261.22B | 5.40B | 3.94B | 18.31 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-22-25 | Initiated | Evercore ISI | In-line |
| May-01-25 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-06-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Oct-08-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-07-24 | Downgrade | Jefferies | Buy → Hold |
| Oct-07-24 | Downgrade | TD Cowen | Buy → Hold |
| Oct-03-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-02-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-02-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Oct-02-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| Jun-24-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-22-24 | Initiated | Raymond James | Mkt Perform |
| Mar-13-24 | Downgrade | Argus | Buy → Hold |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Jan-26-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jan-25-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-23 | Upgrade | Argus | Hold → Buy |
| Nov-08-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-07-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-23-23 | Downgrade | Argus | Buy → Hold |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Oct-26-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-20-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Initiated | Bernstein | Mkt Perform |
| Apr-13-22 | Upgrade | UBS | Neutral → Buy |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Nov-04-21 | Reiterated | Barclays | Overweight |
| Nov-04-21 | Reiterated | Credit Suisse | Outperform |
| Nov-04-21 | Reiterated | Morgan Stanley | Overweight |
| Nov-04-21 | Reiterated | Oppenheimer | Outperform |
| Nov-04-21 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Sep-09-21 | Resumed | Barclays | Overweight |
| Jul-09-21 | Initiated | Seaport Global Securities | Neutral |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Jan-04-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Oct-02-20 | Initiated | Bernstein | Mkt Perform |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-16-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jun-05-20 | Initiated | Goldman | Buy |
| Jan-03-20 | Reiterated | JP Morgan | Overweight |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Sep-30-19 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-12-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Apr-23-19 | Initiated | UBS | Neutral |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Dec-20-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-08-18 | Reiterated | BofA/Merrill | Buy |
| Sep-13-18 | Initiated | Barclays | Overweight |
| Jul-12-18 | Resumed | Morgan Stanley | Overweight |
| Jul-06-18 | Reiterated | Piper Jaffray | Overweight |
| Jun-01-18 | Resumed | Citigroup | Buy |
| Feb-08-18 | Upgrade | Credit Suisse | Neutral → Outperform |
| Feb-08-18 | Reiterated | Leerink Partners | Outperform |
| Jan-12-18 | Upgrade | Jefferies | Hold → Buy |
View All
Humana Inc Stock (HUM) Latest News
Jim Cramer: Humana (HUM) Keeps Rising – A “Totally Independent” Healthcare Stock - MSN
How Humana Inc. stock performs in stagflationMarket Weekly Review & Daily Risk Controlled Trade Plans - newser.com
Why Humana Inc. stock is a must watch in 2025Weekly Trade Recap & Low Risk Profit Maximizing Plans - newser.com
Humana Inc. stock outlook for YEAR2025 Bull vs Bear & Risk Adjusted Buy and Sell Alerts - newser.com
Women CFOs Outperform. Here’s How Humana And Merck Prove It - Forbes
Using economic indicators to assess Humana Inc. potentialJuly 2025 Summary & Comprehensive Market Scan Reports - newser.com
Humana : Invitation to presentation of Humana's report on third quarter 2025 - MarketScreener
Attention Long-Term Shareholders of Amylyx Pharmaceuticals, - GlobeNewswire
How to escape a deep drawdown in Humana Inc.Trade Entry Summary & Precise Buy Zone Identification - newser.com
Humana Inc. $HUM is Pzena Investment Management LLC's 10th Largest Position - MarketBeat
Leith Wheeler Investment Counsel Ltd. Raises Holdings in Humana Inc. $HUM - MarketBeat
Truist Financial Corp Sells 2,231 Shares of Humana Inc. $HUM - MarketBeat
Allspring Global Investments Holdings LLC Reduces Stock Holdings in Humana Inc. $HUM - MarketBeat
US Bancorp DE Has $7.76 Million Holdings in Humana Inc. $HUM - MarketBeat
Can Humana Inc. stock sustain market leadershipWeekly Trade Recap & Fast Moving Market Watchlists - newser.com
Will Humana Inc. stock deliver shareholder valueMarket Trend Report & Trade Opportunity Analysis - newser.com
How institutional ownership impacts Humana Inc. stock2025 Top Gainers & Verified Entry Point Signals - newser.com
Is Humana Inc. stock poised for growthQuarterly Investment Review & Precise Buy Zone Identification - newser.com
Is Humana Inc. stock oversold or undervaluedGDP Growth & Fast Gain Stock Trading Tips - newser.com
What makes Humana Inc. stock attractive to growth funds2025 Momentum Check & Smart Swing Trading Techniques - newser.com
Sivik Global Healthcare LLC Buys 4,000 Shares of Humana Inc. $HUM - MarketBeat
How Humana Inc. (HUM) stock benefits from digital adoptionQuarterly Performance Summary & Daily Volume Surge Signals - newser.com
Humana (NYSE:HUM) Price Target Raised to $300.00 at Bank of America - MarketBeat
Is Humana a Bargain After Recent Stock Slide and Mixed Performance in 2025? - Yahoo Finance
Court Orders Humana to Pay $90M in Groundbreaking Whistleblower Medicare Fraud Case Settlement - Healthcare Innovation
Humana pulls Part D plans from brokerage portals - Modern Healthcare
Humana Inc. to Release Third Quarter 2025 Results on November 5, 2025 - Business Wire
Humana (HUM) Receives Maintained Rating and Raised Price Target from B of A Securities | HUM Stock News - GuruFocus
Humana’s Patrick Nugent applies his extensive broker experience to deliver superior employee benefits across the Chicago region - The Business Journals
Humana’s Mitch Kumagai on why smarter, healthier benefits matter for Bay Area businesses and employees - The Business Journals
2026 MA Star Ratings: Aetna, Humana see scores decline; UnitedHealthcare improves - Fierce Healthcare
Winners and losers from 2026 Medicare Advantage star ratings - Healthcare Dive
Humana stock price target maintained at $290 by Cantor Fitzgerald - Investing.com
How Humana Inc. (HUM) stock correlates with oil marketsQuarterly Investment Review & Safe Entry Momentum Tips - newser.com
Using Ichimoku Cloud for Humana Inc. technicalsJuly 2025 Weekly Recap & Fast Exit and Entry Strategy Plans - newser.com
KLP Kapitalforvaltning AS Raises Stock Position in Humana Inc. $HUM - MarketBeat
CVS, UnitedHealth, Elevance, Humana Gain Price Target Hikes Wall Street After Medicare Star Ratings Update - MSN
Humana, Aetna fall in 2026 Medicare Advantage star ratings - Modern Healthcare
Humana hosts open house to help navigate health insurance changes - WKRC
How Humana’s Rich Blanchard helps D.C. employers create benefits packages that attract and retain top talent - The Business Journals
Why Humana (HUM) is a Top Value Stock for the Long-Term - sharewise.com
Analyst Mizuho Raises Humana (HUM) Price Target to $345 | HUM St - GuruFocus
Mizuho Adjusts Price Target on Humana to $345 From $300, Maintains Outperform Rating - MarketScreener
Order flow analysis tools used on Humana Inc.Weekly Loss Report & Risk Adjusted Swing Trade Ideas - newser.com
Will Humana Inc. stock benefit from upcoming earnings reportsWeekly Gains Report & Detailed Earnings Play Strategies - newser.com
Using Python tools to backtest Humana Inc. strategies2025 Macro Impact & Breakout Confirmation Trade Signals - newser.com
Humana's (HUM) Sell (D+) Rating Reaffirmed at Weiss Ratings - MarketBeat
Humana says talks with Mercy Health still ongoing - The Paducah Sun
Humana’s SWOT analysis: medicare giant faces stars challenge, seeks growth - Investing.com
Bon Secours may become out-of-network care for SC residents on Medicaid, Medicare - Greenville Online
Mercy Health threatens to terminate Humana contract for Medicaid, Medicare Advantage plans - LimaOhio.com
Humana Inc Stock (HUM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):